Diagnos Laboratorium Utama Tbk. vs Esa Medika Mandiri Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Esa Medika Mandiri Tbk. trades at Rp358 (market cap 620.46B, 8.41M 24h volume). The key difference: Esa Medika Mandiri Tbk. is the larger of the two by market cap, and Esa Medika Mandiri Tbk. is more actively traded (8.41M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | EMMI | |
|---|---|---|
Market Cap | 316.25B | 620.46B |
Volume | 41.7K | 8.41M |
Lot | 417 | 84.09K |
Turnover | 9.66M | 2.92B |
Average Price | 231.65 | 347.69 |
Value | 9.66M | 2.92B |
Indicative Equilibrium Price | 230 | 358 |
Indicative Equilibrium Volume | 2.4K | 3.01K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Read more on EMMI →